🔎 Trials Near Me

Home › Geographic Atrophy › Texas › Austin

Geographic Atrophy clinical trials in Austin, TX

7 studies for Geographic Atrophy are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

RecruitingPhase 2
  • Austin Retina Associates, Austin
Ages 55 to 90 · All sexes · Updated Sep 23, 2026 · NCT06557460

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

RecruitingPhase 1/2
  • Retina Consultants of Austin- Site Number : 8400015, Austin
  • Austin Clinical Research - Austin - Anderson Mill Road- Site Number : 8400007, Austin
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

RecruitingPhase 3
  • Austin Research Center for Retina, Austin
  • Austin Retina Associates, Austin
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

RecruitingPhase 2/3
  • Austin Clinical Research, Austin
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT06635148

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

RecruitingPhase 2
  • Austin Retina Associates, Austin
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

RecruitingPhase 1
  • Austin Retina Associates, Austin
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07230834

Geographic Atrophy trials in other cities

Other studies in Austin

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.